1 From Cardiovascular Research Center (CSIC-ICCC), IIB-HSCSP, Barcelona, Spain (G.V., L.C., L.V., L.B.); Radiology Unit (M.G, A.C., A.H.), Cardiology Unit (F.C., G.P.L.), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden (L.C.); CIBERCV, Instituto Salud Carlos III, Barcelona, Spain (L.B.); and Cardiovascular Research Chair UAB, Autonomous University of Barcelona, Bellaterra, Spain (L.B.).